← brief for 2026-09-30 · Slowing decline
Finerenone in IgA nephropathy: A Systematic Review of Real-world Studies.
Key takeaways
This is a review of real-world studies on finerenone, a drug used to slow kidney decline. It looks at how the drug works in people with IgA nephropathy. There are no new results from this item yet.
Who did this work
Yang C · Chen P · Xiong J
Source
Article · PubMed, the drug frontier · 2026 Sep 30
https://pubmed.ncbi.nlm.nih.gov/42811736/